Home > Insider Trading > Filing (0000899243-21-031614)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841387	Candel Therapeutics Inc.	CADL	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-29	679,158	$0.00	679,158	No	4	C	Indirect	By Paul B. Manning Revocable Trust
Common Stock	Acquisiton	2021-07-29	553,752	$0.00	553,752	No	4	C	Indirect	By BKB Growth Investments, LLC
Common Stock	Acquisiton	2021-07-29	1,625,000	$8.00	1,681,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Paul B. Manning Revocable Trust
No	4	C	Indirect	By BKB Growth Investments, LLC
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2021-07-29	1,669,303	$0.00	679,158	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-07-29	1,361,069	$0.00	553,752	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Includes shares held jointly with spouse.